Evidence map›Paper›PMID 32429496›Full record

ArticleBiomolecules2020

Chronic High-Fat Diet Induces Early Barrett's Esophagus in Mice through Lipidome Remodeling.

Jeffrey Molendijk, Thi-My-Tam Nguyen, Ian Brown, Ahmed Mohamed, Yenkai Lim, Johanna Barclay, Mark P Hodson, Thomas P Hennessy, Lutz Krause, Mark Morrison and 1 more

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Dietary fat and lipid metabolism in the tumor microenvironment.Biochimica et biophysica acta. Reviews on cancer · 2023
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Jeffrey MolendijkQIMR Berghofer Medical Research Institute, Herston, Brisbane 4006, QLD, Australia.
Thi-My-Tam NguyenUQ Diamantina Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, Brisbane 4072, QLD, Australia.
Ian BrownEnvoi Specialist Pathologists, Herston, Brisbane 4059, QLD, Australia.
Ahmed MohamedQIMR Berghofer Medical Research Institute, Herston, Brisbane 4006, QLD, Australia.
Yenkai LimUQ Diamantina Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, Brisbane 4072, QLD, Australia.
Johanna BarclayMater Research Institute, The University of Queensland, Woolloongabba, Brisbane 4059, QLD, Australia.
Mark P HodsonUQ Diamantina Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, Brisbane 4072, QLD, Australia.
Thomas P HennessyUQ Diamantina Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, Brisbane 4072, QLD, Australia.
Lutz KrauseUQ Diamantina Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, Brisbane 4072, QLD, Australia.
Mark MorrisonUQ Diamantina Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, Brisbane 4072, QLD, Australia.
Michelle M HillQIMR Berghofer Medical Research Institute, Herston, Brisbane 4006, QLD, Australia.
The University of Queensland · AUQIMR Berghofer Medical Research Institute · AU

Funding

Australian Postgraduate Research Award n/aTranslational Research Institute Spore Grant
6 · The paper itself

Abstract

Esophageal adenocarcinoma (EAC) incidence has been rapidly increasing, potentially associated with the prevalence of the risk factors gastroesophageal reflux disease (GERD), obesity, high-fat diet (HFD), and the precursor condition Barrett's esophagus (BE). EAC development occurs over several years, with stepwise changes of the squamous esophageal epithelium, through cardiac metaplasia, to BE, and then EAC. To establish the roles of GERD and HFD in initiating BE, we developed a dietary intervention model in C57/BL6 mice using experimental HFD and GERD (0.2% deoxycholic acid, DCA, in drinking water), and then analyzed the gastroesophageal junction tissue lipidome and microbiome to reveal potential mechanisms. Chronic (9 months) HFD alone induced esophageal inflammation and metaplasia, the first steps in BE/EAC pathogenesis. While 0.2% deoxycholic acid (DCA) alone had no effect on esophageal morphology, it synergized with HFD to increase inflammation severity and metaplasia length, potentially via increased microbiome diversity. Furthermore, we identify a tissue lipid signature for inflammation and metaplasia, which is characterized by elevated very-long-chain ceramides and reduced lysophospholipids. In summary, we report a non-transgenic mouse model, and a tissue lipid signature for early BE. Validation of the lipid signature in human patient cohorts could pave the way for specific dietary strategies to reduce the risk of BE in high-risk individuals.

Indexed as

Disease Models, AnimalLipid MetabolismAdenocarcinomaAnimalsBarrett EsophagusDeoxycholic AcidDiet, High-FatEsophageal MucosaEsophageal NeoplasmsGastric MucosaGastrointestinal MicrobiomeMaleMiceMice, Inbred C57BLDeoxycholic AcidBarrett’s esophaguscardiac metaplasiaesophageal adenocarcinomalipidlipidomicsmicrobiota

Identifiers

PMID32429496
PMCPMC7277507
OpenAlexW3024480685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.